[Abdominal surgery: what's new in 2023]
Marwan-Julien Sleiman1, Annamaria Jelip1, Jonathan Douissard1
1Service de chirurgie viscérale, Département de chirurgie, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue Medicale Suisse
|January 17, 2024
Summary
Robotic surgery is expanding in procedures and platforms, particularly in parietal, œso-gastric, and liver surgeries. Innovations in oncology, like immunotherapy, and new obesity medications are also transforming patient care.
Area of Science:
- Surgical innovation and oncology advancements.
- Multidisciplinary obesity management.
Context:
- Robotic surgery experienced significant growth in procedures and platforms in 2023.
- Exploration of parietal, œso-gastric, and liver robotic surgery.
Purpose:
- To illustrate the expansion of robotic surgery in specific surgical fields.
- To highlight the synergy between surgical innovation and oncological advancements.
- To review developments in obesity management.
Summary:
- Robotic surgery is increasingly adopted for parietal, œso-gastric, and liver procedures.
- Immunotherapy offers new strategies for colorectal cancer and improves outcomes in liver and œso-gastric surgeries.
- New medications complement surgical interventions for optimal obesity management.
Impact:
- Enhanced patient outcomes through minimally invasive techniques and advanced oncological treatments.
- Diversified treatment options in obesity management, with surgery remaining a key intervention.
- The integration of technology and novel therapies is reshaping surgical practice and patient care.
